drugset / Trial / NCT06328062

Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA

NCT06328062

Recruiting 80 enrolled Thammasat University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty. The main question\[s\] it aims to answer are: • Does mirogabalin have better pain reduction than pregabalin after unilateral primary total knee arthroplasty. Participants will randomized to mirogabalin or pregabalin group and will take the drug for 6 weeks after TKA. Researchers will compare to pregabalin group to see pain and functional outcomes after TKA.

Timeline

Start
2024-04-01
Primary completion
2025-05-31
Completion
2025-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirogabalin Small molecule 5 mg Oral
Comparator Pregabalin Small molecule 50 mg

Indications